These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 31234952

  • 1. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
    Lee SJ, Kim TW, Park GL, Hwang YS, Cho HJ, Kim JT, Lee HG.
    BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
    [Abstract] [Full Text] [Related]

  • 2. G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells.
    Vo DH, Hartig R, Weinert S, Haybaeck J, Nass N.
    Biomolecules; 2019 Sep 18; 9(9):. PubMed ID: 31540491
    [Abstract] [Full Text] [Related]

  • 3. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF, Avino S, Pellegrino M, De Francesco EM, De Marco P, Lappano R, Vivacqua A, Cirillo F, Rigiracciolo DC, Scarpelli A, Abonante S, Maggiolini M.
    Cell Death Dis; 2015 Jul 30; 6(7):e1834. PubMed ID: 26225773
    [Abstract] [Full Text] [Related]

  • 4. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y, Birnbaumer L, Teng CT.
    Mol Endocrinol; 2010 May 30; 24(5):969-80. PubMed ID: 20211987
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q, Chen Z, Jiang G, Zhou Y, Yang X, Huang H, Liu H, Du J, Wang H.
    Mol Cancer; 2017 May 05; 16(1):87. PubMed ID: 28476123
    [Abstract] [Full Text] [Related]

  • 6. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E, Prossnitz ER.
    BMC Cancer; 2015 Oct 15; 15():702. PubMed ID: 26470790
    [Abstract] [Full Text] [Related]

  • 7. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
    De Francesco EM, Pellegrino M, Santolla MF, Lappano R, Ricchio E, Abonante S, Maggiolini M.
    Cancer Res; 2014 Aug 01; 74(15):4053-64. PubMed ID: 24894716
    [Abstract] [Full Text] [Related]

  • 8. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
    Catalano S, Giordano C, Panza S, Chemi F, Bonofiglio D, Lanzino M, Rizza P, Romeo F, Fuqua SA, Maggiolini M, Andò S, Barone I.
    Breast Cancer Res Treat; 2014 Jul 01; 146(2):273-85. PubMed ID: 24928526
    [Abstract] [Full Text] [Related]

  • 9. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.
    Ribeiro MPC, Santos AE, Custódio JBA.
    Chem Biol Interact; 2017 Nov 01; 277():176-184. PubMed ID: 28947257
    [Abstract] [Full Text] [Related]

  • 10. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M, Schüler S, Lattrich C, Ignatov A, Ortmann O, Treeck O.
    Steroids; 2013 Nov 01; 78(11):1087-91. PubMed ID: 23921077
    [Abstract] [Full Text] [Related]

  • 11. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
    Chimento A, Sirianni R, Casaburi I, Zolea F, Rizza P, Avena P, Malivindi R, De Luca A, Campana C, Martire E, Domanico F, Fallo F, Carpinelli G, Cerquetti L, Amendola D, Stigliano A, Pezzi V.
    Oncotarget; 2015 Aug 07; 6(22):19190-203. PubMed ID: 26131713
    [Abstract] [Full Text] [Related]

  • 12. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Pupo M, Pisano A, Abonante S, Maggiolini M, Musti AM.
    Int J Biochem Cell Biol; 2014 Jan 07; 46():56-67. PubMed ID: 24275097
    [Abstract] [Full Text] [Related]

  • 13. GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells.
    Yu T, Cheng H, Ding Z, Wang Z, Zhou L, Zhao P, Tan S, Xu X, Huang X, Liu M, Peng M, Qiu YA.
    Mol Cell Endocrinol; 2020 Apr 15; 506():110762. PubMed ID: 32087276
    [Abstract] [Full Text] [Related]

  • 14. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C, Liao Y, Fan S, Tang H, Jiang Z, Zhou B, Xiong J, Zhou S, Zou M, Wang J.
    Med Oncol; 2015 Apr 15; 32(4):104. PubMed ID: 25744245
    [Abstract] [Full Text] [Related]

  • 15. GPER-induced signaling is essential for the survival of breast cancer stem cells.
    Chan YT, Lai AC, Lin RJ, Wang YH, Wang YT, Chang WW, Wu HY, Lin YJ, Chang WY, Wu JC, Yu JC, Chen YJ, Yu AL.
    Int J Cancer; 2020 Mar 15; 146(6):1674-1685. PubMed ID: 31340060
    [Abstract] [Full Text] [Related]

  • 16. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S, Chen Z, Jiang G, Zhou Y, Liu Q, Su Q, Wei W, Du J, Wang H.
    Cancer Lett; 2017 Feb 01; 386():12-23. PubMed ID: 27836733
    [Abstract] [Full Text] [Related]

  • 17. GPER stabilizes F-actin cytoskeleton and activates TAZ via PLCβ-PKC and Rho/ROCK-LIMK-Cofilin pathway.
    Wang Z, Sun L, Liang S, Liu ZC, Zhao ZY, Yang J, Wang D, Yang DQ.
    Biochem Biophys Res Commun; 2019 Aug 27; 516(3):976-982. PubMed ID: 31277940
    [Abstract] [Full Text] [Related]

  • 18. Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells.
    Chimento A, Casaburi I, Bartucci M, Patrizii M, Dattilo R, Avena P, Andò S, Pezzi V, Sirianni R.
    Cell Death Dis; 2013 Aug 01; 4(8):e747. PubMed ID: 23907461
    [Abstract] [Full Text] [Related]

  • 19. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
    Tao S, He H, Chen Q, Yue W.
    Biochem Biophys Res Commun; 2014 Aug 15; 451(1):74-8. PubMed ID: 25063027
    [Abstract] [Full Text] [Related]

  • 20. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J, Liu M, Yang L, Tu G, Zhu Q, Chen M, Cheng H, Luo H, Fu W, Li Z, Yang G.
    Breast Cancer Res; 2015 May 21; 17(1):69. PubMed ID: 25990368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.